Looks like you clickedhttps://www.astrazeneca.com/media-centre/medical-releases/evusheld-long-acting-antibody-combination-retains-neutralising-activity-against-omicron-variants-including-ba2-in-new-independent-studies.html
If you do not want to visit that page, you can close this browser tab.
